<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03591120</url>
  </required_header>
  <id_info>
    <org_study_id>DeliriumPreventionProtocol</org_study_id>
    <nct_id>NCT03591120</nct_id>
  </id_info>
  <brief_title>Delirium Prevention Protocol in Elderly Patients</brief_title>
  <official_title>A Randomized, Controlled Trial Reviewing the Effectiveness of a Preventative Delirium Protocol in Elderly Patients While Analyzing Its Consequential Effects on Awareness, Post-operative Nausea and Vomiting, and/or Pain Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study aims to elucidate the effectiveness of a preventative delirium protocol in
      patients older than 65 years of age undergoing elective surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A comprehensive analysis of patient specific risk factors and predisposing perioperative risk
      factors will be completed. The objective is to see if delirium incidences are significantly
      lower in the group that receives a preventative delirium protocol compared to a control
      group, while not increasing other adverse undesirable side effects. We hypothesize that a
      preventative delirium protocol will reduce the incidence of delirium compared to the control
      group (primary outcome), but this protocol may lead to increased side effects such as PONV,
      poor pain control, and increased awareness (secondary outcomes).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of delirium (CAM-ICU)</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Delirium defined by Post-operative CAM, using the validated CAM-ICU measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Post-operative Nausea and Vomiting</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Post-operative Nausea and Vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Rating Scale</measure>
    <time_frame>Within one post-operative day</time_frame>
    <description>Numerical Rating Scale of Pain Intensity, 0-10 scale. Value of 0 is No Pain. Value of 10 is Worst Pain Imaginable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject will receive anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preventative Delirium Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consider regional block if applicable
Minimized fentanyl usage intraoperatively
Intubation + general anesthesia adjunct total: 1-2 mcg/kg fentanyl
Sedation: 0-0.24 mcg/kg fentanyl
Post-operative: 0.5 - 1 mcg/kg fentanyl
Avoid morphine
Avoid ketamine
Avoid diphenhydramine, dexamethasone, scopolamine, metoclopramide, and promethazine
Avoid H2-blockers (cimetidine, ranitidine, famotidine)
Avoid polypharmacy intraoperatively if possible (i.e. &gt; 5 new medications)
Fluid repletion based on maintenance and losses</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Standard of Care without Preventative Delirium Protocol</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Preventative Delirium Protocol</intervention_name>
    <description>Preventative Delirium Protocol</description>
    <arm_group_label>Preventative Delirium Protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 65 years

          -  Scheduled for Elective Surgery (outpatient/same-day admit)

        Exclusion Criteria:

          -  Need emergency surgery

          -  Need intracranial surgery

          -  Dependent on opiate narcotics

          -  Surgeon-specified perioperative procedures that precludes the current study's protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asokumar Buvanendran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert J McCarthy, PharmD</last_name>
    <phone>312-942-7608</phone>
    <email>Robert_J_McCarthy@rush.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David H Kim, MD</last_name>
    <phone>702-588-3470</phone>
    <email>david_h_kim@rush.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert J McCarthy, PharmD</last_name>
      <phone>312-563-0448</phone>
      <email>Robert_J_McCarthy@rush.edu</email>
    </contact>
    <contact_backup>
      <last_name>David H Kim, MD</last_name>
      <phone>702-588-3470</phone>
      <email>david_h_kim@rush.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bilotta F, Doronzio A, Stazi E, Titi L, Zeppa IO, Cianchi A, Rosa G, Paoloni FP, Bergese S, Asouhidou I, Ioannou P, Abramowicz AE, Spinelli A, Delphin E, Ayrian E, Zelman V, Lumb P. Early postoperative cognitive dysfunction and postoperative delirium after anaesthesia with various hypnotics: study protocol for a randomised controlled trial--the PINOCCHIO trial. Trials. 2011 Jul 6;12:170. doi: 10.1186/1745-6215-12-170.</citation>
    <PMID>21733178</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 6, 2018</study_first_submitted>
  <study_first_submitted_qc>July 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2018</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Robert J McCarthy</investigator_full_name>
    <investigator_title>Research Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

